skip to main content
Guest
My Research
My Account
Sign out
Sign in
This feature requires javascript
Library Search
Find Databases
Browse Search
E-Journals A-Z
E-Books A-Z
Citation Linker
Help
Language:
English
Vietnamese
This feature required javascript
This feature requires javascript
Primo Search
All Library Resources
All
Course Materials
Course Materials
Search For:
Clear Search Box
Search in:
All Library Resources
Or hit Enter to replace search target
Or select another collection:
Search in:
All Library Resources
Search in:
Print Resources
Search in:
Digital Resources
Search in:
Online E-Resources
Advanced Search
Browse Search
This feature requires javascript
Search Limited to:
Search Limited to:
Resource type
criteria input
All items
Books
Articles
Images
Audio Visual
Maps
Graduate theses
Show Results with:
criteria input
that contain my query words
with my exact phrase
starts with
Show Results with:
Search type Index
criteria input
anywhere in the record
in the title
as author/creator
in subject
Full Text
ISBN
ISSN
TOC
Keyword
Field
Show Results with:
in the title
Show Results with:
anywhere in the record
in the title
as author/creator
in subject
Full Text
ISBN
ISSN
TOC
Keyword
Field
This feature requires javascript
Comparison of curative effects of intravitreal injection of Ranibizumab and Conbercept in the treatment of diabetic macular edema
Guo ji yan ke za zhi, 2018-01, Vol.18 (1), p.59-62
[Peer Reviewed Journal]
ISSN: 1672-5123 ;EISSN: 1672-5123 ;DOI: 10.3980/j.issn.1672-5123.2018.1.13
Full text available
Citations
Cited by
View Online
Details
Recommendations
Reviews
Times Cited
External Links
This feature requires javascript
Actions
Add to My Research
Remove from My Research
E-mail
Print
Permalink
Citation
EasyBib
EndNote
RefWorks
Delicious
Export RIS
Export BibTeX
This feature requires javascript
Title:
Comparison of curative effects of intravitreal injection of Ranibizumab and Conbercept in the treatment of diabetic macular edema
Author:
Yang Guo
;
Li-Ting Hou
;
Hong-Xia Hu
;
Yan-Zhu Ren
Subjects:
conbercept
;
diabetic macular edema
;
intravitreal injection
;
ranibizumab
Is Part Of:
Guo ji yan ke za zhi, 2018-01, Vol.18 (1), p.59-62
Description:
AIM: To comparatively analyze curative effects of intravitreal injection of Ranibizumab and Conbercept in the treatment of diabetic macular edema. METHODS: Retrospectively analyzed the clinical data of 110 patients(110 eyes)with diabetic macular edema treated in our hospital from January 2015 to January 2016, divided them into two groups according to the different treatment. Of these, treated 55 eyes with ranibizumab intravitreal injections(ranibizumab group)and the other with conbercept intravitreal injections(conbercept group), the injection came once a month for 8 continuous months with a 6-month follow-up. Compared the changes of visual acuity, macular thickness, postoperative comfort, clinical efficacy and complications between the two groups after treatment. RESULTS: There was no significant difference in LogMAR visual acuity between the two groups before treatment(P>0.05). The visual acuity of the patients in the ranibizumab group and conbercept group were significantly improved after 1mo treatment, F were 42.06 and 64.02 respectively(P<0.01), but there was no significant difference between the two groups after 1mo treatment(P>0.05). The visual acuity of the conbercept group was significantly higher than that of the ranibizumab group after 3 and 6mo treatment(P<0.05). There was no significant difference in macular thickness between the two groups before treatment(P>0.05), the thickness of the macular fovea in the ranibizumab group and conbercept group was lower than that before treatment, there were statistically significant differences(P<0.01); the decline range of conbercept group were more than those of the ranibizumab group after 3 and 6mo(P<0.05). Patients comfort of the two groups improved with the passage of time after surgery, and there was no significant difference between the two groups(P>0.05), there were no significant differences in the total effective rate and complication of the ranibizumab group(87.3%, 1.8%)and the conbercept group(85.5%, 3.6%)(P>0.05). CONCLUSION: In the treatment of diabetic macular edema, the early vision of patients with diabetic macular edema increases significantly, and the macular thickness decreases significantly. Conbercept works better and has a longer lasting effect after 3 and 6mo treatment, and conbercept is more economical.
Publisher:
Press of International Journal of Ophthalmology (IJO PRESS)
Language:
English
Identifier:
ISSN: 1672-5123
EISSN: 1672-5123
DOI: 10.3980/j.issn.1672-5123.2018.1.13
Source:
DOAJ Directory of Open Access Journals
This feature requires javascript
This feature requires javascript
Back to results list
This feature requires javascript
This feature requires javascript
Searching Remote Databases, Please Wait
Searching for
in
scope:(TDTS),scope:(SFX),scope:(TDT),scope:(SEN),primo_central_multiple_fe
Show me what you have so far
This feature requires javascript
This feature requires javascript